ndotracheal suctioning (ES) is an essential and frequently performed procedure for patients requiring mechanical ventilation. By ES, secretions from the tracheobronchial tree are cleared, guaranteeing optimal oxygenation and avoiding accumulation of secretions, leading to tube occlusion, increased work of breathing, atelectasis, and pulmonary infections (1) (2) (3) (4) (5) (6) (7) . Yet ES may also have adverse effects, such as disturbances in cardiac rhythm, hypoxemia (due to interruption of the mechanical ventilation and subsequently the decay of intrathoracic pressure), microbial contamination of airway and environment, and development of ventilator-associated pneumonia (VAP).
The frequency with which ES is performed differs per patient, with reported mean values varying from eight to 17 times per day (1, 8 -13) . Nowadays, two systems are available to perform ES: the single-use, open suction system (OSS) and the multiple-use, closed suction system (CSS). OSS requires disconnection from the ventilator during ES, which is not necessary when using CSS. Moreover, in contrast to OSS, the closed suction catheter can remain connected to the patient for as long as 24 hrs, according to the manufacturer, and thus can be used for multiple ES procedures (14) .
CSS has become increasingly popular in the past decade. In the United States, 58% and 4% of intensive care units (ICUs) exclusively used CSS and OSS, respectively (15) .
Preference of CSS more than OSS is mainly based on assumed advantages, like lower incidence of VAP, fewer physiologic disturbances, decreased microbial contamination (and thus lower risk on cross-infections), and lower costs (8, 10, 16) . In a recently published international guideline for the prevention of VAP, it was suggested that cost considerations favor the use of CSS that is changed as indicated, and the system is therefore recommended. This advice, however, is based on one trial that compared costs of CSS with or without daily changes of the system; trials on costeffectiveness of CSS compared with OSS are lacking (17) .
So far, the evidence to prefer CSS more than OSS has not been systematically reviewed. Therefore, we performed a meta-analysis in which we compared the effectiveness of CSS with that of OSS with respect to infection and survival, cardiorespiratory variables, bacterial contamination, and costs. Two reviewers independently assessed abstracts of the identified references to identify relevant studies for inclusion. Full reports were retrieved from all studies that fulfilled the inclusion criteria, that is, including adult mechanically ventilated ICU patients, comparing CSS and OSS, and measuring outcomes with respect to either infection and survival, cardiorespiratory variables, bacterial contamination, or costs. Furthermore, the randomization procedure was critically appraised. To prevent manipulation of the allocation process, the method of assigning patients to either CSS or OSS should be adequately concealed for both patient and clinician (healthcare worker). This method was judged by two reviewers without masking of author or source, using four ratings for quality of allocation concealment (18):
METHODS

Design
A. Adequate concealment of the allocation B. Uncertainty about adequate concealment of allocation C. Allocation definitely not adequately concealed D. Allocation concealment not used Discrepancies in ratings were resolved through discussion between reviewers. No additional information was sought from the original authors.
Data Analysis. From each study, data were extracted on the outcomes measured. For continuous outcomes on cardiorespiratory variables, data during and after ES were extracted when provided. When data were obtained several moments after ES, the worst values were selected.
The synthesis of data was performed using random effect models. These models are preferable, since performance of ES differs between units and even nurses. For dichotomous outcomes, relative risks were calculated. For continuous outcomes, both weighted mean difference (for outcomes measured on the same scale) and standardized mean difference (outcomes measured on different scales, e.g., assessing mean arterial pressure [MAP] by using invasive or noninvasive techniques) were calculated. All effect measures were reported with 95% confidence intervals (CI).
To assess heterogeneity of treatment effects across studies, I
2 statistic was computed in Review Manager (version 4.2.8, The Cochrane Collaboration, Software Update, Oxford, UK). I 2 is derived from Cochrane's Q statistic (19) . It measures the extent of inconsistency among the studies' results, and the outcome is interpreted as the percentage of total variation across studies that is due to heterogeneity rather than chance (19, 20) . A value of 0% indicates that all variability in effect estimates is due to chance and that none is due to heterogeneity. Larger values show that most of the variability is due to heterogeneity rather than chance. When the I 2 was Ͼ25% (i.e., Ͼ25% of the variability is due to heterogeneity), no pooled effect estimates were calculated. Furthermore, when there was uncertainty about results because of differences in criteria to measure outcomes (e.g., VAP), sensitivity analyses were performed, in which only studies with comparable criteria were included. 
RESULTS
Initially, 106 articles were identified (Fig. 1) . Eighty-four studies were excluded because no comparison was made between OSS or CSS (e.g., only CSS or OSS was evaluated) or randomization was not applied. Twenty-six articles were considered potentially relevant, of which 15 met the criteria for this review. The other 11 articles were excluded due to a) failure to apply randomization (10, 14, 16, (21) (22) (23) ; b) no relevant data being extractable (24 -26); c) duplicate publication (27) ; and d) language (28) .
Sample size varied from 9 to 457 patients in the included studies ( Table  1) . Details of randomization (such as methods or procedures) were not provided in nine studies. Although randomization methods were provided in the remaining six studies, details about mode of concealment were not mentioned. Two studies used inadequate allocation methods, like date of intubation and bed availability (18, 29) . Adequate approaches for concealment, such as a random numbers table, use of a computer system that generated a random number, and sealed envelopes were used in four studies.
Effects on Infection and Survival. VAP incidences were determined in eight studies (Table 2) (Fig. 2) .
Effects on patient survival were determined in four studies (I 2 0%; p ϭ .86) (Fig. 3) (8, 9, 31, 32) . No difference in ICU mortality was found (pooled relative risk, 1.02; 95% CI, 0.84 -1.25). In only one study were valid data on length of ICU stay given, and they were in favor of OSS (31) .
Effects on Cardiorespiratory Variables. Effects of ES system on physiologic outcomes, that is, arterial oxygen saturation (SaO 2 ), PaO 2 , mixed venous oxygen saturation, heart rate, and MAP, were determined in six studies (Table 3) ( 1, 11, [33] [34] [35] [36] .
Three studies evaluated changes in MAP by using either an arterial catheter or a noninvasive blood pressure cuff (I 2 0%; p ϭ .51) (Fig. 4) (1, 33, 34) . A pooled standardized mean difference was calculated, since MAP was measured using different scales (invasive and noninvasive). MAP was significantly higher after using OSS (pooled standardized mean difference, Ϫ0.43; 95% CI, Ϫ0.87 to 0.00). However, the absolute difference was rather small (3-5 mm Hg difference).
Effects of ES system on SaO 2 , measured by pulse oximetry, were determined in five studies, but there was substantial overall heterogeneity (I 2 86.1%; p Ͻ .00001), so pooled analyses could not be performed (Fig. 5) (1, 11, 33, 34, 36 ). There was a difference in subcategories: Three studies that evaluated changes in SaO 2 during ES (I 2 0%; p Ͻ .56) revealed a nonsignificant difference in weighted mean difference of 0.92% (95% CI, Ϫ0.58 to 2.41). The other five studies evaluating the changes after ES could not be pooled due to substantial heterogeneity (I 2 90.5%; p Ͻ .00001). All studies favored CSS, with slightly higher mean values and smaller standard deviations. However, mean differences were rather small within SaO 2 , varying from 96 -99% after CSS to 95-98% after OSS. In one study, a larger decrease in SaO 2 was observed, from 97% after CSS to 90% after OSS (11) .
Changes in heart rate, traced by electrocardiogram monitoring, were evaluated in four studies (1, 33, 34, 36) (I 2 4.6%, p ϭ .39) (Fig. 6) . The pooled weighted mean difference was Ϫ6.33 beats/min in favor of CSS (95% CI, Ϫ10.80 to Ϫ1.87). Although this difference was statistically significant, it is questionable whether it is clinically relevant.
Two studies determined the effect of ES system on PaO 2 by using an arterial catheter, but pooled analyses could not be performed due to substantial heterogeneity (I 2 67%; p ϭ .08) (Fig. 7) (33, 35) . In both crossover studies, a larger decrease in PaO 2 was observed after using OSS, even up to a 60% decrease in one study (35) . This decrease may have been influenced by duration of ES, which was, in both studies, 20 secs instead of the recommended maximum of 15 secs. Above that, Lasocki et al. (35) performed a recruitment maneuver of 20 tidal volumes after CSS, which was not applied after OSS.
Differences in mixed venous oxygen saturation were determined in only one study (1); CSS was favored (mean mixed venous oxygen saturation 74% with CSS and 67% with OSS).
Effects on Bacterial Contamination and Secretion Volume. Bacterial contamination after ES was evaluated in one study (11) . More specifically, colonization of bronchial tree and stomach was assessed. After 3 days, simulta- Multiple use of CSS may lead to bacterial colonization of the endoluminal surface of the tube, and on reuse of the suction catheter these bacteria may autocontaminate the patient's respiratory tract. Two studies compared bacterial colonization of endotracheal tubes when using OSS or CSS (I 2 0%; p ϭ .44) (Fig. 8) (9, 31) . The pooled risk ratio was 1.51 (95% CI, 1.12-2.04) for CSS, implying that colonization of endotracheal tubes occurs less frequently with OSS. Yet, in both studies colonization differences were not associated with differences in development of VAP (9, 31) .
Quantities of secretions removed were compared in two studies (35, 37) in which OSS and CSS were used in alternating order with 3-to 6-hr intervals in the same patients. There was too much heterogeneity (I 2 40.4%; p ϭ .20), so a pooled weighted mean difference could not be calculated (Fig. 9 ). Both studies found that OSS was more effective in removing tracheobronchial secretions (mean weight of 2.5-.2 g with OSS and 0.6 -2.3 g with CSS).
Costs. Costs were compared in five studies (1, 8, 12, 13, 32) (Table 4) , and material costs of CSS were 14 -100 times more expensive than OSS. When we analyzed costs per day and with number of ES procedures per day ranging from 10 to 16, CSS remained three to almost 12 times more expensive in three studies (8, 12, 13) . The fact that CSS reduces use of gloves, masks, and glasses during ES was taken into account in all three studies. Use of CSS appeared to be cost-effective in two studies, due to smaller price differences between both systems (1) or to extended use of CSS (32) .
DISCUSSION
The results of this meta-analysis reveal that generally assumed advantages of CSS compared with OSS, like lower incidences of VAP, lower costs, reduced bacterial contamination, and improved patient outcome, are not supported by scientific evidence. The only assump-tion that is supported by evidence is that CSS causes fewer physiologic disturbances, but the differences were rather small and do not seem clinically relevant.
Few studies (n ϭ 15) have compared the effects of OSS and CSS in a randomized design. In general, the methodological quality of the included studies was not high. Although all trials used some kind of randomization, methods of concealment were provided in only six studies, of which only four were considered adequate. Inadequate or unclear allocation concealment may lead to larger es- timates of effect (29) . Furthermore, performance of ES was not described accurately in most studies and differed between studies in the use of normal saline, preoxygenation, or duration of suctioning (10 -20 secs). The latter aspects may have profound effects on physiologic variables such as oxygenation and heart rate. Finally, when we considered studies assessing the effects of different ES systems and the risk on VAP, patient categories and criteria to diagnose VAP differed somewhat. In all studies noninvasive methods were used to diagnose VAP, and main differences were in the specification of leukocytosis (Ͻ3000 or Ͻ4000/mm 3 ) and the necessity of all criteria to be met.
Although studies differed in methodology (design and conduct) as well as clinically (patient characteristics and performance of ES), a meta-analysis could be performed for five outcomes, since heterogeneity was low. The most frequently evaluated outcome variable was VAP, which was determined in eight studies. A significant reduction associated with the use of CSS was only found in the smallest study (n ϭ 24) (11). Neither in the larger studies nor in meta-analysis were significant incidence reductions found, as was also concluded in a recently published metaanalysis (38) . Because of differences in diagnosis of VAP, we performed a sensitivity analysis that included only those studies that used comparable criteria to diagnose VAP (1, 4, 8, 9, 30, 32) , and findings did not alter (I 2 0%; pooled relative risk, 0.95; 95% CI, 0.76 -1.20). Therefore, it seems unlikely that subsequent and larger randomized trials will change this finding. This interpretation conflicts with recently published international guidelines in which the use of CSS is recommended as part of a VAP prevention strategy (17, 39) . These recommendations are based on qualitative analyses of three (39) or four (17) similar randomized studies, which all conclude that type of suctioning system has no effect on the incidence of VAP. Despite this lack of evidence (and without performing a meta-analysis), both guidelines favor CSS.
The second largest outcome measured was mortality (four studies, 1062 patients), and no significant differences were found in either of the studies or in meta-analysis. Statistically significant differences were found in cardiorespiratory variables: MAP and heart rate were lower after using CSS. However, the actual difference for heart rate was 6 beats/ min and seems, therefore, of little clinical relevance. This also applies to MAP, in which we found a significant but clinically very small difference (3-5 mm Hg) in favor of CSS. There is no evidence that CSS is beneficial for arterial oxygen saturation. This outcome was higher after using OSS in each study, but the five studies were too heterogeneous to perform pooled analysis. Despite differences in cardiorespiratory variables, it is not possible to draw firm conclusions due to the paucity and clinical heterogeneity of data.
Available data do not support the idea that CSS is cost reducing compared with OSS. A rigorous costeffectiveness analysis of both systems is needed and should include the societal perspective (real costs being made to perform ES, e.g., used materials and personnel time) and benefits (in terms of patient outcomes) across the healthcare continuum (40) . Prolongation of CSS device use, from the recommended 24 hrs to several days, will definitely influence cost efficacy. This approach has been pursued in six studies (3, 32, (41) (42) (43) (44) . Prolonged use of CSS was associated with increased microbial colonization of the device (43) without raising the incidence of VAP (3, 41, 44) and was considered safe and cost-effective (3, (41) (42) (43) (44) . A survey among 27 ICUs in the United States revealed that CSS devices were changed every 72 hrs, "as needed," or weekly in 37% of ICUs (45), with no negative effects mentioned.
Conceptually, prevention of bacterial transmission from patient to patient could be a beneficial, and highly relevant, effect of using CSS instead of OSS. However, up to now cross-transmission or environmental bacterial contamination has not been studied in a randomized design. Environmental contamination after ES with either OSS or CSS was compared in a nonrandomized crossover study with nine patients (16) . After 144 ES procedures, both OSS and CSS were associated with significant increased colony counts measured by air sampling, but, on average, colony counts were lower after use of CSS (16) . In another small observational study (n ϭ 14), visible droplet dissemination was detected in all OSS procedures, with bacteriologic contamination in the inanimate environment of 37% of patients (46) . There are no data on environmental contamination when changing the CSS device, a procedure that also needs tube disconnection. Interestingly, the assumed reduction in environmental contamination is a reason to use CSS, not only to minimize cross-transmission of pathogens but also to allow performance of ES without the use of sterile gloves, which are recommended when using OSS (47) . Without scientific justification, such a change in nursing practice may in fact increase hand contamination and subsequent spread of nosocomial pathogens. This meta-analysis has some limitations. First, as in all meta-analyses, publication bias cannot be excluded. A funnel plot of the included studies on the incidence of VAP (data not shown) indeed indicated that publication bias might play a role; that is, larger studies showing beneficial effect appear to be missing. This is, however, in contrast with the concerns about publication bias, namely that positive (significant) results in favor of the newer system (CSS) are more likely to be published than negative results (type I error) (48, 49) .
Second, selection bias might have occurred as a consequence of our language restriction. As far as we know, we only missed one Korean study on the effects of CSS on arterial oxygen saturation and VAP in 70 patients (28) . We could not assess study quality, randomization procedures, and criteria used to diagnose VAP (incidence significantly higher in OSS group). Results on arterial oxygen saturation could, however, be read from the tables and were in agreement with our findings.
This first meta-analysis on open and closed suction systems reveals that the increased popularity of CSS is yet not sufficiently supported by scientific evidence. Randomized trials to assess one of the most pronounced assumptions, the potential benefits of CSS in reducing cross-transmission, are needed. Such trials should be specifically designed to identify the true effect measures. When randomizing individual patients, resulting in a mix of patients receiving ES with CSS and OSS, beneficial effects of CSS might be obscured by cross-transmission occurring from neighbor patients randomized to OSS. Therefore, a large multiple-center crossover trial, with fixed periods in which either of both systems is used, appears to be most appropriate.
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